![](/img/cover-not-exists.png)
Retrospective Real-World Adherence in Patients With Type 2 Diabetes Initiating Once-Daily Liraglutide 1.8 mg or Twice-Daily Exenatide 10 μg
Malmenäs, Maria, Bouchard, Jonathan R., Langer, JakobVolume:
35
Language:
english
Journal:
Clinical Therapeutics
DOI:
10.1016/j.clinthera.2013.03.021
Date:
June, 2013
File:
PDF, 289 KB
english, 2013